» Articles » PMID: 34645875

Assessment of Bone Quality with Trabecular Bone Score in Patients with Inflammatory Bowel Disease

Overview
Journal Sci Rep
Specialty Science
Date 2021 Oct 14
PMID 34645875
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) patients have a significant risk of developing bone loss. The trabecular bone score (TBS) is a relatively new parameter used to provide information on bone quality. The study cohort included 81 patients with IBD and 81 healthy controls. Blood tests, dual-energy x-ray absorptiometry (DXA), including TBS, were assessed. Harvey-Bradshaw Index (HBI) for Crohn's disease (CD) and the Partial Mayo Score for ulcerative colitis (UC) were used for evaluation of clinical disease activity. Compared with the healthy controls, the IBD patients had lower lumbar spine (LS) bone mineral density (BMD) (1.06 ± 0.18 vs. 1.16 ± 0.15 g/cm, p < 0.005), hip BMD (0.88 ± 0.13 vs. 0.97 ± 0.13 g/cm, p < 0.005) and TBS (1.38 ± 0.1 vs. 1.43 ± 0.1, p < 0.005) values. The patients with stricturing CD had lower TBS (1.32 ± 0.13 vs. 1.40 ± 0.9, p = 0.03) and LS BMD (0.92 ± 0.19 vs. 1.07 ± 0.1, p = 0.01) values compared with those with non-stricturing CD. Multivariate regression model analysis identified HBI as independent factor associated with TBS. Our results support that all DXA parameters are lower in patients with IBD than in healthy patients. Moreover, TBS is a valuable tool for assessment of bone impairment in active CD.

Citing Articles

Association of Immune-Mediated Inflammatory Diseases and Fracture Risk in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.

Kim Y, Kwon O, Kim R, Kim J, Kim M, Park M J Clin Med. 2025; 14(3).

PMID: 39941466 PMC: 11818108. DOI: 10.3390/jcm14030795.


A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk.

Marild K, Soderling J, Axelrad J, Halfvarson J, Forss A, Michaelsson K Aliment Pharmacol Ther. 2024; 60(11-12):1549-1560.

PMID: 39308339 PMC: 11599792. DOI: 10.1111/apt.18275.


Vitamin D and malabsorptive gastrointestinal conditions: A bidirectional relationship?.

Giustina A, Di Filippo L, Allora A, Bikle D, Cavestro G, Feldman D Rev Endocr Metab Disord. 2023; 24(2):121-138.

PMID: 36813995 PMC: 9946876. DOI: 10.1007/s11154-023-09792-7.


Degraded Bone Microarchitecture in Women with PHPT-Significant Predictor of Fracture Probability.

Oprea T, Barbu C, Martin S, Sarbu A, Duta S, Nistor I Clin Med Insights Endocrinol Diabetes. 2023; 16:11795514221145840.

PMID: 36698384 PMC: 9869236. DOI: 10.1177/11795514221145840.


Secondary Osteoporosis and Metabolic Bone Diseases.

Sobh M, Abdalbary M, Elnagar S, Nagy E, Elshabrawy N, Abdelsalam M J Clin Med. 2022; 11(9).

PMID: 35566509 PMC: 9102221. DOI: 10.3390/jcm11092382.


References
1.
Bryant R, Ooi S, Schultz C, Goess C, Grafton R, Hughes J . Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 41(9):895-906. DOI: 10.1111/apt.13156. View

2.
Larsen S, Bendtzen K, Nielsen O . Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010; 42(2):97-114. DOI: 10.3109/07853890903559724. View

3.
Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Faustini F, Simon D . High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients. J Crohns Colitis. 2016; 10(5):532-40. PMC: 4957457. DOI: 10.1093/ecco-jcc/jjw012. View

4.
Hidalgo D, Boonpheng B, Phemister J, Hidalgo J, Young M . Inflammatory Bowel Disease and Risk of Osteoporotic Fractures: A Meta-Analysis. Cureus. 2019; 11(9):e5810. PMC: 6823062. DOI: 10.7759/cureus.5810. View

5.
Boussoualim K, Amouzougan A, Pallot-Prades B, Denarie D, Collet P, Marotte H . Evaluation of bone quality with trabecular bone score in active spondyloarthritis. Joint Bone Spine. 2018; 85(6):727-731. DOI: 10.1016/j.jbspin.2018.02.006. View